Search Results for: FGFR1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
GRB2 growth factor receptor bound protein 2
  • Interleukin-15 signaling
  • Interleukin-15 signaling
  • Signaling by CSF3 (G-CSF)
  • Signaling by CSF3 (G-CSF)
  • STAT5 activation downstream of FLT3 ITD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by FLT3 ITD and TKD mutants
  • Signaling by ALK fusions and activated point mutants
  • Signaling by LTK
  • Pegademase
  • 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid
HTR1A 5-hydroxytryptamine receptor 1A
  • Serotonin receptors
  • Eletriptan
  • Ziprasidone
  • Methysergide
  • Cabergoline
  • Zolmitriptan
  • Dihydroergotamine
  • Amitriptyline
  • Olanzapine
  • Clozapine
  • Loxapine
  • Pramipexole
  • Methylphenidate
  • Imipramine
  • Chlorpromazine
  • Buspirone
  • Haloperidol
  • Nortriptyline
  • Amoxapine
  • Propranolol
  • Fenfluramine
  • Lisuride
  • Trazodone
  • Sumatriptan
  • Ergotamine
  • Apomorphine
  • Paroxetine
  • Trimipramine
  • Risperidone
  • Alprenolol
  • Ondansetron
  • Oxymetazoline
  • Naratriptan
  • Pindolol
  • Dopamine
  • Ergoloid mesylate
  • Doxepin
  • Nefazodone
  • Desipramine
  • Escitalopram
  • Pergolide
  • Bromocriptine
  • Ketamine
  • Quetiapine
  • Aripiprazole
  • Chlorprothixene
  • Paliperidone
  • Penbutolol
  • Yohimbine
  • Acepromazine
  • Alverine
  • Molindone
  • Pipotiazine
  • Lysergic acid diethylamide
  • Dapoxetine
  • Bifeprunox
  • Flibanserin
  • Iloperidone
  • Lofexidine
  • Lesopitron
  • Rotigotine
  • MN-305
  • LI-301
  • Naluzotan
  • Cariprazine
  • Mianserin
  • Pizotifen
  • Asenapine
  • Xaliproden
  • Dotarizine
  • Sarizotan
  • Repinotan
  • Robalzotan
  • Vilazodone
  • Bopindolol
  • Cinitapride
  • Lurasidone
  • Perospirone
  • Cannabidiol
  • Vortioxetine
  • Brexpiprazole
  • Dosulepin
  • Pirlindole
  • Tianeptine
  • Setiptiline
  • Dihydroergocornine
  • Tetrahydrocannabivarin
  • Pardoprunox
  • Gilteritinib
  • Lecozotan
  • Lecozotan
  • Tiapride
  • Dihydroergocristine
  • Medical Cannabis
  • 5-methoxy-N,N-dimethyltryptamine
  • Nabiximols
  • Aripiprazole lauroxil
  • SEP-363856
  • Serdexmethylphenidate
HULC hepatocellular carcinoma up-regulated long non-coding RNA
IL17RD interleukin 17 receptor D
  • MAP2K and MAPK activation
ITGB3 integrin subunit beta 3
  • Platelet degranulation
  • Elastic fibre formation
  • PECAM1 interactions
  • Molecules associated with elastic fibres
  • Integrin cell surface interactions
  • Integrin cell surface interactions
  • TGF-beta receptor signaling activates SMADs
  • Syndecan interactions
  • Syndecan interactions
  • ECM proteoglycans
  • Integrin signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • p130Cas linkage to MAPK signaling for integrins
  • VEGFA-VEGFR2 Pathway
  • Signal transduction by L1
  • MAP2K and MAPK activation
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Mechanical load activates signaling by PIEZO1 and integrins in osteocytes
  • Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells
  • Abciximab
  • Eptifibatide
  • Antithymocyte immunoglobulin (rabbit)
  • Levothyroxine
  • Tirofiban
  • Resveratrol
  • Lefradafiban
  • LM-609
  • Fradafiban
  • Ferric maltol
  • Allograft rejection
  • Glanzmann thrombasthenia
ITK IL2 inducible T cell kinase
  • Generation of second messenger molecules
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Staurosporine
  • Pazopanib
  • Fostamatinib
  • Zanubrutinib
KLB klotho beta
  • PI3K Cascade
  • PIP3 activates AKT signaling
  • betaKlotho-mediated ligand binding
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Phospholipase C-mediated cascade; FGFR4
  • FRS-mediated FGFR4 signaling
  • SHC-mediated cascade:FGFR4
  • PI-3K cascade:FGFR4
  • Negative regulation of FGFR4 signaling
  • RAF/MAP kinase cascade
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
KPNB1 karyopherin subunit beta 1
  • ISG15 antiviral mechanism
  • Apoptosis induced DNA fragmentation
  • Regulation of cholesterol biosynthesis by SREBP (SREBF)
  • Transport of Ribonucleoproteins into the Host Nucleus
  • NS1 Mediated Effects on Host Pathways
  • Nuclear import of Rev protein
  • Nuclear import of Rev protein
  • Initiation of Nuclear Envelope (NE) Reformation
  • Neutrophil degranulation
  • Assembly of the ORC complex at the origin of replication
  • Interferon alpha/beta signaling
  • Postmitotic nuclear pore complex (NPC) reformation
  • Inhibition of nitric oxide production
  • SARS-CoV-1 activates/modulates innate immune responses
  • Maturation of hRSV A proteins
L1CAM L1 cell adhesion molecule
  • Basigin interactions
  • L1CAM interactions
  • L1CAM interactions
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • Signal transduction by L1
  • Ethanol
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
  • L1 syndrome, including: ; X-linked hydrocephalus; MASA syndrome; X-linked complicated spastic paraplegia type I ; X-linked partial agenesis of corpus callosum
  • Hereditary spastic paraplegia (SPG)
LDHA lactate dehydrogenase A
  • Pyruvate metabolism
  • Regulation of pyruvate metabolism
  • NADH
  • Etheno-NAD
  • Nicotinamide
  • Oxamic Acid
  • Stiripentol
  • Copper
  • Artenimol
MFHAS1 multifunctional ROCO family signaling regulator 1
MMP2 matrix metallopeptidase 2
  • Collagen degradation
  • Collagen degradation
  • Degradation of the extracellular matrix
  • Degradation of the extracellular matrix
  • Activation of Matrix Metalloproteinases
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • EPH-ephrin mediated repulsion of cells
  • Interleukin-4 and Interleukin-13 signaling
  • Extra-nuclear estrogen signaling
  • Marimastat
  • Captopril
  • SC-74020
  • Halofuginone
  • AE-941
  • Endostatin
  • Oleandrin
  • Choriocarcinoma
  • Penile cancer
  • Torg-Winchester syndrome
NCAM1 neural cell adhesion molecule 1
  • ECM proteoglycans
  • NCAM signaling for neurite out-growth
  • NCAM signaling for neurite out-growth
  • NCAM1 interactions
  • NCAM1 interactions
  • Signal transduction by L1
  • RAF/MAP kinase cascade
  • Interferon gamma signaling
NCK1 NCK adaptor protein 1
  • Downstream signal transduction
  • Generation of second messenger molecules
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • Nephrin family interactions
  • DCC mediated attractive signaling
  • DCC mediated attractive signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • RHOU GTPase cycle
  • RHOV GTPase cycle
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • Potential therapeutics for SARS
  • PKR-mediated signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
NCK2 NCK adaptor protein 2
  • Downstream signal transduction
  • Nephrin family interactions
  • Ephrin signaling
  • Activation of RAC1
  • VEGFA-VEGFR2 Pathway
  • Regulation of cortical dendrite branching
  • RHOU GTPase cycle
  • RHOV GTPase cycle
NECTIN1 nectin cell adhesion molecule 1
  • Adherens junctions interactions
  • Nectin/Necl trans heterodimerization
  • Isolated orofacial clefts, including: Cleft lip with or without cleft palate; Cleft palate
NEDD4 NEDD4 E3 ubiquitin protein ligase
  • ISG15 antiviral mechanism
  • Downregulation of ERBB4 signaling
  • Regulation of PTEN localization
  • Regulation of PTEN stability and activity
  • Antigen processing: Ubiquitination & Proteasome degradation
NRG1 neuregulin 1
  • Signaling by ERBB2
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PI3K events in ERBB4 signaling
  • SHC1 events in ERBB4 signaling
  • Nuclear signaling by ERBB4
  • PIP3 activates AKT signaling
  • GRB7 events in ERBB2 signaling
  • Downregulation of ERBB2:ERBB3 signaling
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Downregulation of ERBB2 signaling
  • Long-term potentiation
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 TMD/JMD mutants
NRP1 neuropilin 1
  • Neurophilin interactions with VEGF and VEGFR
  • Signaling by ROBO receptors
  • Sema3A PAK dependent Axon repulsion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion
  • CRMPs in Sema3A signaling
  • CRMPs in Sema3A signaling
  • Signal transduction by L1
  • CHL1 interactions
  • Attachment and Entry
OR51B4 olfactory receptor family 51 subfamily B member 4
  • Expression and translocation of olfactory receptors

Page 6 out of 8 pages